Watchlist Price Alert

ASLAN Pharmaceuticals Limited (ASLN)

NASDAQ: ASLN · Real-Time Price · USD

0.60

-0.10 (-14.27%)

At close: Jul 18, 2024, 8:00 PM

ASLAN Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	21.25M	56.9M	90.17M	14.32M	22.2M	28.91M	50.53M	51.56M
Short-Term Investments	n/a	n/a	n/a	137.93K	n/a	n/a	n/a	n/a
Long-Term Investments	235.57K	8.59K	494.73K	n/a	200.42K	247.25K	n/a	n/a
Other Long-Term Assets	1.72K	8.59M	n/a	103.31K	108.08K	172.08K	160.8K	124.34K
Receivables	171.44K	n/a	n/a	528.84K	n/a	n/a	n/a	1.29M
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.00
Other Current Assets	2.71M	3.98M	3.61M	649.13K	68.85K	183.6K	71.89K	89.26K
Total Current Assets	24.13M	60.88M	93.78M	15.5M	22.27M	29.09M	50.6M	52.94M
Property-Plant & Equipment	259.25K	292.74K	232.72K	475.94K	766.2K	288.42K	443.16K	383.06K
Goodwill & Intangibles	1.72K	5.84K	9.96K	160.00	2.85K	23.08M	83.99K	83.99K
Total Long-Term Assets	496.53K	307.16K	737.41K	579.4K	1.08M	23.79M	687.95K	591.39K
Total Assets	24.63M	61.19M	94.52M	16.08M	23.35M	52.88M	51.29M	53.53M
Account Payables	7.92M	12.78M	3.12M	2.32M	1.87M	5.32M	3.89M	2.27M
Deferred Revenue	n/a	n/a	2.82M	4.28M	n/a	n/a	n/a	n/a
Short-Term Debt	2.03M	7.96M	199.12K	3.79M	264.54K	n/a	n/a	n/a
Other Current Liabilities	3.17M	2.42M	223.35K	267K	3.25M	2.68M	2.08M	1.52M
Total Current Liabilities	13.11M	23.16M	6.36M	10.66M	5.38M	8M	5.97M	3.79M
Long-Term Debt	24.8M	29.66M	30.86M	15.46M	18.12M	13.97M	9.67M	8.31M
Other Long-Term Liabilities	-24.8M	n/a	n/a	111.99K	447.22K	289.61K	161.85K	n/a
Total Long-Term Liabilities	24.8M	29.66M	30.86M	15.58M	18.57M	14.26M	9.83M	8.31M
Total Liabilities	37.91M	52.82M	37.21M	26.23M	23.95M	22.26M	15.81M	12.1M
Total Debt	26.83M	37.62M	31.06M	19.26M	18.39M	13.97M	9.67M	8.31M
Common Stock	63.93M	63.02M	63.02M	61.83M	61.37M	51.63M	43.84M	35.63M
Retained Earnings	-321.07M	-278.39M	-227M	-195.68M	-179.48M	-132.47M	-93.46M	-48.22M
Comprehensive Income	24.07M	-178.95K	-178.95K	-178.95K	-55.08K	-512.8K	1.67M	4.03M
Shareholders Equity	-13.29M	8.37M	57.3M	-10.45M	-1.68M	30.62M	35.48M	41.43M
Total Investments	235.57K	8.59K	494.73K	137.93K	200.42K	247.25K	n/a	n/a